These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5272118)

  • 1. [Effect of cytosine-arabinoside in hemoblastoses].
    Hermanský F; Friedmann B; Benesová E
    Vnitr Lek; 1970 Jul; 16(7):632-7. PubMed ID: 5272118
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of acute myeloid leukemia and myelodysplastic syndrome by low dose arabinosyl cytosine.
    Baccarani M; Fasola G; Fanin R; Morassi P; Florean M; Pozzato G; Cavazzini G; Zaccaria A; Guarini L; Lodi L
    Haematologica; 1985; 70(2):160-5. PubMed ID: 3924780
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-dose cytosine-arabinoside in the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
    Weh HJ; Zschaber R; Hossfeld DK
    Blut; 1984 Apr; 48(4):239-42. PubMed ID: 6585241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low doses of cytarabine in the treatment of myelodysplastic syndrome and acute myeloid leukemia.
    Mufti GJ; Oscier DG; Hamblin TJ; Bell AJ
    N Engl J Med; 1983 Dec; 309(26):1653-4. PubMed ID: 6580526
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cytosine arabinoside in the therapy of acute leukoses].
    Quaglino D; De Pasquale A; Curci G; Montero C; Piccinini L
    Minerva Med; 1971 Jun; 62(45):2271-82. PubMed ID: 5281484
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cytosine-arabinoside in the treatment of acute myeloblastic leukemias].
    Maroncelli P; Canova R; Casalino C; Fischioni P
    Minerva Med; 1971 Mar; 62(21):1110-9. PubMed ID: 5279670
    [No Abstract]   [Full Text] [Related]  

  • 7. [Abnormalities of the erythropoiesis at the beginning of remission in acute promyelocytic leukemia treated with arabinoside-cytosine].
    Dubois-Ferrière H; Aguercif M; Hazeghi P; Rudhardt M
    Schweiz Med Wochenschr; 1970 Feb; 100(7):321-3. PubMed ID: 5263342
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytosine arabinoside therapy for acute myeloid leukaemia in adults.
    Buchanan JG
    N Z Med J; 1971 Sep; 74(471):153-9. PubMed ID: 5289827
    [No Abstract]   [Full Text] [Related]  

  • 9. Low dose cytosine arabinoside in the treatment of acute non-lymphocytic leukemias and myelodysplastic syndromes.
    Tambone Reyes M; Bonaccorso R; Gebbia V; Tinnirello D; Di Salvo V; Ciulla A; Di Marco P; Mansueto S; Citarrella P
    J Chemother; 1989 Jul; 1(4 Suppl):1276-8. PubMed ID: 16312864
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of acute leukemias in the infancy with cytosine arabinoside].
    Madon E; Baroncelli PG; Sacerdote A; Roberi PL
    Minerva Pediatr; 1971 Jun; 23(26):1125-9. PubMed ID: 5286310
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of acute leukosis in children with arabinosyl cytosine].
    Plüss HJ; Hitzig WH
    Schweiz Med Wochenschr; 1971 Dec; 101(49):1783-4. PubMed ID: 5291102
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
    Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low-dose cytosine arabinoside treatment in acute myeloid leukemia].
    Jensen MK; Ahlbom G; Leegaard OF
    Ugeskr Laeger; 1984 Aug; 146(35):2613-5. PubMed ID: 6595867
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-dose cytosine arabinoside in the treatment of acute nonlymphoblastic leukemia and myelodysplastic syndromes.
    Hoelzer D; Ganser A; Schneider W; Heimpel H
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):208-11. PubMed ID: 4012339
    [No Abstract]   [Full Text] [Related]  

  • 15. Low dose cytosine arabinoside in the treatment of acute non-lymphoblastic leukemia.
    Insiripong S; Thaisamakr S
    J Med Assoc Thai; 1996 Sep; 79(9):568-71. PubMed ID: 8996985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Low-dose cytosine arabinoside in the treatment of myeloblastic leukemia].
    Beris P; Chapuis B
    Schweiz Rundsch Med Prax; 1984 Sep; 73(39):1167-8. PubMed ID: 6593780
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combined therapy with mitoxantrone and cytosine arabinoside as a first-line treatment in ANLL: preliminary results].
    Angós JA; Gutiérrez M; Moreno JA; Aguado MJ; Romero MS
    Sangre (Barc); 1993 Jun; 38(3):250-1. PubMed ID: 8211557
    [No Abstract]   [Full Text] [Related]  

  • 18. [Electron microscopic bone marrow changes in acute leukemias before and after cytosin-arabinoside therapy].
    Ruzicka F; Weigerstorfer B
    Verh Dtsch Ges Inn Med; 1973; 79():369-72. PubMed ID: 4524459
    [No Abstract]   [Full Text] [Related]  

  • 19. Coordinated changes in biochemical patterns: the effect of cytosine arabinoside and methotrexate on leukocytes from patients with acute granulocytic leukemia.
    Roberts D; Hall TC; Rosenthal D
    Cancer Res; 1969 Mar; 29(3):571-8. PubMed ID: 5251290
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cytokinetic effect of cytosine arabinoside in clinical tests].
    Barlogie B; Büchner T; Asseburg U; Kamanabroo D
    Med Welt; 1974 Sep; 25(39):1532-4. PubMed ID: 4530133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.